一种与恶性疟原虫感染红细胞表面VAR2CSA共定位的不变蛋白结合硫酸软骨素A
本研究鉴定了一种与妊娠疟疾相关的恶性疟原虫硫酸软骨素A配体(PfCSA-L)。重组PfCSA-L以纳摩尔亲和力结合胎盘硫酸软骨素A和VAR2CSA,并在感染红细胞表面与VAR2CSA共表达,通过高亲和力蛋白-蛋白相互作用外周关联于结节外表面。PfCSA-L保守、暴露于感染细胞且与VAR2CSA共定位,是有前景的干预靶点。
要点
- 重组PfCSA-L以纳摩尔亲和力结合胎盘硫酸软骨素A和VAR2CSA。
- PfCSA-L在感染红细胞表面与VAR2CSA共表达并共定位。
- PfCSA-L通过高亲和力蛋白相互作用外周关联于结节外表面,不依赖跨膜结构域。
核心结论
- PfCSA-L是一种保守、暴露于感染红细胞表面且与VAR2CSA共表达和共定位的蛋白,是有前景的干预靶点。
- 感染红细胞隔离可能涉及不变和变异表面蛋白的复合物,使寄生虫在感染红细胞表面维持多样性和功能。
研究设计与样本
- 本研究对与妊娠疟疾相关的恶性疟原虫硫酸软骨素A配体(PfCSA-L)进行表征。
主要发现
- 重组PfCSA-L以纳摩尔亲和力结合胎盘硫酸软骨素A和VAR2CSA。
- PfCSA-L在感染红细胞表面与VAR2CSA共表达。
- 与通过跨膜结构域锚定的VAR2CSA不同,PfCSA-L通过高亲和力蛋白-蛋白相互作用与VAR2CSA外周关联于结节外表面。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Plasmodium falciparum-infected red blood cells (iRBCs) bind and sequester in deep vascular beds, causing malaria-related disease and death. In pregnant women, VAR2CSA binds to chondroitin sulfate A (CSA) and mediates placental sequestration, making it the major placental malaria (PM) vaccine target. METHODS: In this study, we characterize an invariant protein associated with PM called P falciparum chondroitin sulfate A ligand (PfCSA-L). RESULTS: Recombinant PfCSA-L binds both placental CSA and VAR2CSA with nanomolar affinity, and it is coexpressed on the iRBC surface with VAR2CSA. Unlike VAR2CSA, which is anchored by a transmembrane domain, PfCSA-L is peripherally associated with the outer surface of knobs through high-affinity protein-protein interactions with VAR2CSA. This suggests that iRBC sequestration involves complexes of invariant and variant surface proteins, allowing parasites to maintain both diversity and function at the iRBC surface. CONCLUSIONS: The PfCSA-L is a promising target for intervention because it is well conserved, exposed on infected cells, and expressed and localized with VAR2CSA.
引用
- Keitany GJ, Jenkins BJ, Obiakor HT, et al. An Invariant Protein That Colocalizes With VAR2CSA on Plasmodium falciparum-Infected Red Cells Binds to Chondroitin Sulfate A. J Infect Dis. 2022. PMID: 34718641. doi:10.1093/infdis/jiab550
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。